| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |